INVESTIGATE THE ABILITY TO PRODUCE CYTOKINE OF CAR-T CELL
Main Article Content
Abstract
Objectives: The study on IL-2, TNF-α and IFN secretion of CAR-T cell when co-incubation CD19 + cancer cell lines. Method: Interleukin generation of CAR-T cell when co-culture with other cells (K562, Daudi, 1D2, PBMC cells) was evaluated at 24 and 48 hours after culture. IL-2, TNF-α and IFN were quantified using the probiotics IL-2, TNF alpha, IFN gamma Human ELISA Kit (Thermo Fisher Scientific). Results: At both 24 and 48 hours, the higher concentrations of cytokines IFN-γ, IL-12, and TNF-α in the CAR-T cell cultures when cultured with cancer cells with CD19 + statistical significance (p <0.05) compared with the concentration of IFN-γ, IL-12, TNF-α in the culture of above cells and PBMC cells (control group). In addition, the concentrations of these cytokines in CAR-T cell cultures were both higher when cultured with CD19 + cancer cells than when cultured with CD19- cells. Conclusion: Our CAR-T product has the ability to generate IFN-γ, IL-12, TNF-α and increase generation when co-cultured with CD19 positive cells.
Article Details
Keywords
CAR-T cell, IL-2, IL2, IFN-γ, TNF-α, CD19 positive
References
2. Novartis, Prescribing Information (Kymriah™). 2017.
3. D'Aloia, M.M., et al., CAR-T cells: the long and winding road to solid tumors. Cell Death Dis, 2018. 9(3): p. 282.
4. Maude, S.L., et al., Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med, 2014. 371(16): p. 1507-17.
5. Kochenderfer, J.N., et al., Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. J Clin Oncol, 2015. 33(6): p. 540-9.